Prosight Management as of March 31, 2026
Portfolio Holdings for Prosight Management
Prosight Management holds 46 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nektar Therapeutics Com New (NKTR) | 8.7 | $53M | 735k | 71.95 | |
| Boston Scientific Corporation (BSX) | 8.2 | $50M | 796k | 62.75 | |
| Janux Therapeutics (JANX) | 8.1 | $49M | 3.6M | 13.90 | |
| Procept Biorobotics Corp (PRCT) | 8.0 | $49M | 1.9M | 25.01 | |
| Galapagos Nv Spon Adr | 7.6 | $47M | 1.6M | 30.00 | |
| Genedx Holdings Corp Com Cl A (WGS) | 5.5 | $34M | 524k | 64.22 | |
| Shattuck Labs (STTK) | 5.3 | $32M | 5.0M | 6.43 | |
| Adc Therapeutics Sa SHS (ADCT) | 5.1 | $31M | 8.3M | 3.75 | |
| Kura Oncology (KURA) | 4.5 | $27M | 3.4M | 8.13 | |
| Alnylam Pharmaceuticals (ALNY) | 4.1 | $25M | 76k | 330.87 | |
| Meiragtx Holdings (MGTX) | 3.7 | $23M | 2.6M | 8.66 | |
| Alkermes SHS (ALKS) | 3.0 | $18M | 514k | 35.36 | |
| Syndax Pharmaceuticals (SNDX) | 2.9 | $18M | 770k | 23.36 | |
| Veeva Sys Cl A Com (VEEV) | 2.5 | $15M | 87k | 175.66 | |
| Zymeworks Del (ZYME) | 2.2 | $14M | 539k | 25.04 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.1 | $13M | 350k | 36.32 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.9 | $12M | 105k | 111.35 | |
| Concentra Group Holdings Par Common Stock (CON) | 1.8 | $11M | 506k | 21.45 | |
| Terns Pharmaceuticals (TERN) | 1.7 | $11M | 202k | 52.72 | |
| Phreesia (PHR) | 1.5 | $9.2M | 1.1M | 8.38 | |
| Onkure Therapeutics Com Cl A (OKUR) | 1.5 | $8.9M | 2.2M | 4.14 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.1 | $6.5M | 697k | 9.39 | |
| Schrodinger (SDGR) | 1.0 | $5.8M | 511k | 11.36 | |
| Emergent BioSolutions (EBS) | 0.9 | $5.3M | 639k | 8.30 | |
| Roivant Sciences SHS (ROIV) | 0.8 | $5.0M | 180k | 27.70 | |
| Orthopediatrics Corp. (KIDS) | 0.8 | $4.8M | 302k | 15.87 | |
| Immunovant (IMVT) | 0.7 | $4.4M | 176k | 24.84 | |
| ICU Medical, Incorporated (ICUI) | 0.6 | $3.5M | 28k | 129.15 | |
| Tectonic Therapeutic (TECX) | 0.4 | $2.5M | 80k | 30.91 | |
| Rocket Pharmaceuticals (RCKT) | 0.4 | $2.4M | 684k | 3.58 | |
| Upstream Bio (UPB) | 0.4 | $2.2M | 241k | 9.00 | |
| Pliant Therapeutics (PLRX) | 0.3 | $2.1M | 1.7M | 1.26 | |
| Omeros Corporation (OMER) | 0.3 | $1.8M | 175k | 10.56 | |
| Intuitive Surgical Com New (ISRG) | 0.3 | $1.8M | 4.0k | 460.99 | |
| An2 Therapeutics (ANTX) | 0.3 | $1.8M | 516k | 3.42 | |
| Adicet Bio Com New (ACET) | 0.3 | $1.7M | 250k | 6.81 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $1.7M | 200k | 8.38 | |
| Coya Therapeutics Common Stock (COYA) | 0.3 | $1.7M | 420k | 3.94 | |
| Viking Therapeutics (VKTX) | 0.2 | $1.5M | 45k | 32.54 | |
| Irhythm Technologies (IRTC) | 0.2 | $1.2M | 10k | 118.02 | |
| TrueBlue (TBI) | 0.2 | $974k | 249k | 3.91 | |
| Immuneering Corp Class A Com (IMRX) | 0.1 | $650k | 123k | 5.27 | |
| Palvella Therapeutics Inc Ne (PVLA) | 0.1 | $623k | 5.0k | 124.65 | |
| Novocure Ord Shs (NVCR) | 0.1 | $549k | 50k | 10.90 | |
| Rein Therapeutics Com New (RNTX) | 0.1 | $535k | 412k | 1.30 | |
| Transmedics Group (TMDX) | 0.1 | $497k | 5.0k | 99.41 |
